INSTITUT FÜR PHARMAKOLOGIE UND TOXIKOLOGIE

2005-2007

 2007


Ammon-Treiber S., Grecksch G., Angelidis C., Vezyraki P., Höllt V., Becker A.:
Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70. Naunyn Schmiedebergs Arch Pharmacol (2007) 375(2):115-121

Ammon-Treiber S., Stolze D., Höllt V.:
Differential effects of mu-opioid receptor agonists in a hippocampal hypoxia/hypoglycemia model. Brain Res. (2007), Dec. 5;1183:60-5

Börner C., Höllt V., Sebald W., Kraus J.:
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J Leukoc Biol (2007) 81(1) 336-343

Börner C., Stumm R. Höllt V., Kraus J.:
Comparative analysis of mu-opioid receptor expression in immune and neuronal cells. J Neuroimmunol (2007) 188(1-2) 56-63

Börner C., Höllt V., Kraus J.:
Activation of humen T cells induces upregulation of cannabinoid receptor type 1 transcription. Neuroimmunomodulation (2007); 14(6):281-6

Liang YJ., Wu DF., Yang LQ., Höllt V., Koch T.:
Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling. Mol Pharmacol 71 (2007) 123-131

Schulz S., Stumm R., Höllt V.:
Immunofluorescent identification of neuropeptide B-containing nerve fibres and terminals in the rat hypothalamus. Neurosci Lett (2007) 411(1): 67-71

Stumm R., Höllt V.:
CXC chemokine receptor 4 regulates neuronal regeneration in the adult brain. J Mol Endocrinol (2007) 38(3):377-382

Stumm R., Kolodziej A., Schulz S., Kohtz JD., Höllt V.:
Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. J Comp Neurol (2007) 502(3):382-399

Stumm R., Kolodziej A., Prinz V., Endres M., Wu DF., Höllt V.:
Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J Neurochem. (2007) Nov; 103(4):1666-81

Wu DF., Koch T., Liang YJ., Stumm R., Schulz S., Schröder H., Höllt V.:
Membrane Glycoprotein M6a Interacts with the (micro)-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling. J Biol Chem (2007) 282(30) 22239-22247

 

2006


Becker A., Schmitz M., Grecksch G.:
Kindling modifies morphine, cocaine and ethanol place preference. Exp. Brain Res. 168 (2006) 33 - 40

Becker A, Grecksch G. Schröder H.:
Pain sensitivity is altered in animals after subchronic ketamine treatment. Psychopharmacology (2006) Oct 3; [Epub ahead of print]

Becker A, Grecksch G.
Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats. Behav. Brain Res. 166(1) (2006) 177-183

Börner C., Höllt V., Kraus J.:
Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells. Mol Pharmacol 69 (2006) 1486-1491

Grecksch G., Bartzsch K., Widera A., Becker A., Höllt V., Koch T.:
Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology 186(2) (2006) 177-184

Koch T., Wu DF., Yang LQ., Brandenburg LO., Höllt V.:
Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors. J. Neurochem 97 (2006) 365-372

Kraus J., Börner C., Lendeckel U., Höllt V.:
Interferron-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells. J. Neuroimmunol 181 (2006) 13-18

Krugel H., Becker A., Polten A., Grecksch G., Singh R., Berg A., Seidenbecher C., Saluz HP.:
Transcriptional response to the neuroleptic-like compound Ampullosporin A in the rat ketamine model. J. Neurochem 97 Suppl 1 (2006) 74-81

Mayer P., Höllt V.:
Pharmacogenetics of opioid receptors and addiction. Pharmacogenet Genomics 16 (2006) 1-7

Schilling M., Wetzel W., Grecksch G., Becker A.:
Pentylenetetrazole kindling affects sleep in rats. Epilepsia 47 (2006) 2075-2082

Schulz S., Stumm R., Röcken C., Mawrin C., Schulz S.:
Immunolocalization of full-length NK1 tachykinin receptors in human tumors. J. Histochem Cytochem 54 (2006) 1015-1020

Schulz S., Röcken C., Schulz S.:
Immunohistochemical detection of bombensin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies. Virchows Arch 449 (2006) 421-427

Schulz S., Röcken C., Ebert MP., Schulz S.:
Immunocytochemical identification of low-affinity NTS2 neurotensin receptors in parietal cells of human gastric mucosa. J. Endocrinol 191 (2006) 121-128

Schulz S., Röcken C., Schulz S.:
Immunocytochemical localisation of plasma membrane GHRH receptors in human tumors using novel antipeptide antibody. Eur J Cancer 42 (2006) 2390-2396

 

weitere Publikationen 2006


Krugel H., Becker A., Polten A., Grecksch G., Singh R., Berg A., Seidenbecher C., Saluz HP.:
Transcriptional response to the neuroleptic-like compound Ampullosporin A in the rat ketamine model. J. Neurochem. 97 (2006) 74 - 81

Keilhoff G., Becker A., Grecksch G., Bernstein HG.,Wolf, G. :
Cell proliferations is influenced by bulbectomy and normalized by imipramine treatment in a region-specific manner. Neuropsychopharmacology 31 (2006) 1165-1167

 

2005


Ammon-Treiber S., Höllt V.:
Morphine-induced Changes of Gene Expression in the Brain. Addiction Biology 2005, 10, 81-89

Ammon-Treiber S.,Stolze D., Schröder H., Loh H., Höllt V.:
Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 49 /2005) 1160 - 1169

Becker A., Eyles D.W., McGrath J.J., Grecksch G.:
Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behhav. Brain Res. 161 (2005) 306-312

Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg LO., Wundrack N., Beyer A., Grecksch G., Höllt V.:
Receptor Endocytosis Counteracts the Development of Opioid Tolerance. Molecular Pharmacology 67: 280-287, 2005

Mayer P., Höllt V.:
Genetic disposition to addictive disorders -current knowledge and future perspectives. Current Opinion in Pharmacology 2005, 5: 4-8

Stumm R., Rüthrich H., Schulz S., Zhou Ch., Höllt V.:
Expression of the µ-opioid receptor is included in dentate gyrus granule cells after focal cerebrocortical ischaemia and stimulation of entorhinal afferents. Europ. J. of Neuroscience 22 (2005) 1032-1044

weitere Publikationen 2005


Meis S., Sosulina L., Schulz S., Höllt V., Pape H.-C.:
Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala. European Journal of Neuroscience, Vol. 21, pp. 755-762, 2005

Ichikawa H., Schulz S., Höllt V., Mo Z., Xiang M., Sugimoto T.:
Effect of Brn-3a deficiency on primary nociceptors in the trigeminal ganglion. Neurosc. Res. 51 (2005) 445-451

Ichikawa H., Schulz S., Höllt V., Sugimoto T.:
Delta-opioid receptor-immunoreactive neurons in the rat cranial sensory ganglia. Brain Research 1043 (2005) 225-230

Raghavendra Y.Nagaraja, Becker A., Reymann K.G., Balschun D.:
Repeated administration of group I mGluR antagonists prevents seizure-induced long-term aberrations in hippocampal synaptic plasticity. Neuropharmacology 49 (2005) 179-187

Letzte Änderung: 11.03.2020 - Ansprechpartner:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: